Free Trial

Nephros Q3 2024 Earnings Report

Nephros logo
$1.57 -0.03 (-1.63%)
As of 03:50 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Nephros EPS Results

Actual EPS
$0.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Nephros Revenue Results

Actual Revenue
$3.52 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Nephros Announcement Details

Quarter
Q3 2024
Time
After Market Closes

Conference Call Resources

Nephros Earnings Headlines

URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
Nephros, Inc. (NEPH) Q3 2024 Earnings Call Transcript
Nephros’s Strategic Growth and Profitability Drive Buy Rating
See More Nephros Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nephros? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nephros and other key companies, straight to your email.

About Nephros

Nephros (NASDAQ:NEPH), a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

View Nephros Profile

More Earnings Resources from MarketBeat